Can women taking birth control pills help reduce the risk of severe COVID-19?

Between May and June this year, King's College London analysed data from more than 500,000 women using data from a symptom-tracking app to determine the role of estrogen in preventing COVID-19.
55 per cent of people in the vast majority of age groups in England and Wales who have died from COVID-19.
only in the 85-year-old age group, more women than men died, mainly because of the higher number of female elders in this age group.
women have higher levels of estrogen.
generally believed that estrogen affects the number of immune cells produced by the body and their response to infection.
so, does it have this effect on COVID-19? Dr. Karla Lee, who led the study on women who took oral contraceptives with a reduced risk of infection by more than 10 percent, said it was previously assumed that pre-menomandern women had higher levels of estrogen and were less likely to develop severe COVID-19 than post-menopoly women of the same age and body mass index (BMI).
commonly known as deoxyprogegenone estradiol tablets, is a safe, efficient and low-impact third-generation short-acting oral contraceptive pill.
women of childbearing age who take the compound oral contraceptive pill, will the associated incidence decrease? Can these assumptions be validated? Compared with coVID-19 infection in a similar group that was not taken, it was found that the severity of COVID-19 infection was lower among young women taking the compound oral contraceptive pill.
who took the compound oral contraceptive pill, the risk of coVID-19 developing a severe illness decreased by an average of 13%.
suggests that estrogen in the compound oral contraceptive pill may provide some protection.
women between the ages of 18 and 45 who took oral contraceptives had a lower rate of COVID-19 infection and a lower rate of persistent coughing,delirium, anorexia, eating a meal without a meal, severe fatigue, pain, and so on.
who took oral contraceptives between the ages of 18 and 45 also had significantly lower hospitalization rates.
findings support these assumptions.
post-menstrual women, the risk of infection increased by more than 20 percent compared to pre-menstrual women, and the risk of post-menctural women increased by 22 percent.
the study also showed that post-menostrual women were more likely to be infected with COVID-19 than pre-meno menostrual women.
women in the 45-50 age group are most likely to be at risk, with reported symptoms including loss of smell, fever and persistent coughing, with a significantly higher proportion of people in this age group requiring hospital oxygen inhalation.
post-menoconiotic women aged 50-65 who used hormone replacement therapy were associated with the expected increase in COVID-19 infection rates, but not with hospitalization rates.
lack of information about the type of alternative therapy, the route and course of treatment, the researchers suggest that the effects of hormone replacement therapy should be viewed with caution.
the study could also help explain why women are less likely than men to be infected with COVID-19.
Co-author of the paper, Dr Ricardo Costeira, of King's College London, said he hoped the results would help provide information for ongoing biomedical research and clinical trials in the field.
: Ricardo Costeira. Post-menopausal women at higher risk of development severe COVID-19, study finds. Aug 4, 2020.Henry Bodkin. Women who take the take the pill are less likely to develop serious coronavirus, study finds. Aug 4, 2020. Retrieved Aug 5, 2020 from ▽ attention to the Public No.